• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

AGI Biopharmaceuticals

edit

AGI Biopharmaceuticals, Ltd., a European firm that has developed a patented, economic, melanoma vaccine with future multi-cancer application.

Recent Milestones

edit

• 
  AGI Biopharmaceuticals received $4.71M in Venture Round funding. (11/28/11)
  Posted 11/28/11 at 8:54pm via finsmes.com

Videos

Screenshots

edit

Sources

1. AGI Biopharmaceuticals Raises $4.71M in Equity Funding from Mentor Capital (finsmes.com) [edit]